The School of Pharmacy, National Taiwan University (NTU) recently held the third admission information session for its Bachelor’s Degree Program in Biotechnology and Pharmaceutical Sciences, which will begin official enrollment in Academic Year 115.
During the session, Program Director Chia-Ron Yang introduced the background and objectives of the program and explained the increasing demand for talent in Taiwan’s biotechnology and pharmaceutical industries. Assistant Professor Wei-Ren Ko then presented the program curriculum and provided information regarding applications for internal transfer and double majors, followed by a question-and-answer session with attending students.
The program also announced that applications for internal transfer and double majors will open on June 8. In addition, a visit to a pharmaceutical company is planned after the final examinations this semester, providing students with an opportunity to observe pharmaceutical manufacturing and industry operations.
Program Director Chia-Ron Yang noted that Taiwan’s industrial structure has long been influenced by the development of the electronics sector and the healthcare system. As a result, many students tend to pursue fields with well-established career pathways. Even among pharmacy students, many choose to prepare for the national pharmacist licensing examination and pursue careers as clinical pharmacists in hospitals. This trend has resulted in relatively limited participation in the pharmaceutical industry and in new drug development.
The Bachelor’s Degree Program in Biotechnology and Pharmaceutical Sciences was established in response to this situation. The program aims to provide an educational pathway distinct from the traditional clinical orientation by emphasizing pharmaceutical research and development as well as industry-oriented training. Through coursework, pharmaceutical internships, and industry–academia collaboration, the program seeks to help students understand the pharmaceutical industry chain and the process of new drug development while bridging the gap between academic training and industry practice. The program also aims to cultivate a stable pool of core talents with strong research and development potential for Taiwan’s pharmaceutical and biotechnology industries.